IP Library › Granted Patent US 9,834,802
Granted Patent B2
US 9,834,802 · App. 15/445,254 · Granted Dec 5, 2017

Methods for making L-glufosinate

Inventors: Brian Michael Green (Phoenix, MD); Michelle Lorraine Gradley (Canterbury, GB)
Assignee: AgriMetis, LLC
C12P13/02A01N25/30A01N57/20C12N1/20C12N9/10C12P9/00C12P13/04C12P41/00C12Y104/03003C12Y206/01019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,834,802
App. No.
15/445,254
Granted
Dec 5, 2017
Kind
B2
Abstract

Methods for the production of L-glufosinate (also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) are provided. The methods comprise a two-step process. The first step involves the oxidative deamination of D-glufosinate to PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid). The second step involves the specific amination of PPO to L-glufosinate, using an amine group from one or more amine donors. By combining these two reactions, the proportion of L-glufosinate in a mixture of L-glufosinate and D-glufosinate can be substantially increased.

Claims (31)

1. A method for making L-glufosinate, comprising:

reacting D-glufosinate with a D-amino acid oxidase (DAAO) enzyme to form PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid) while aerating; and

aminating the PPO to L-glufosinate by a transaminase (TA) enzyme, using an amine group from one or more amine donors,

wherein at least 70% of the D-glufosinate is converted to L-glufosinate; and

wherein the method is performed ex vivo.

2. The method of claim 1 , wherein the amine donor is glutamate or L-glutamate.

3. The method of claim 1 , wherein the D-glufosinate is originally present in a racemic mixture of D- and L- glufosinate or salts thereof.

4. The method of claim 1 , wherein the DAAO enzyme is a mutant DAAO comprising one or more mutations at positions 54, 56, 58, 213, and 238, using SEQ ID NO: 2 as a reference sequence,

wherein the mutation at position 54 is selected from the group consisting of N54C, N54L, N54T, and N54V; the mutation at position 56 is T56M; and the mutation at position 58 is selected from the group consisting of F58A, F58G, F58H, F58K, F58N, F58Q, F58R, F58S, and F58T.

5. The method of claim 4 , wherein the mutations comprise N54V, F58Q, and M213S.

6. The method of claim 1 , wherein the TA enzyme is an enzyme encoded by SEQ ID NO: 1.

7. The method of claim 1 , wherein the TA enzyme is a GabT transaminase having the amino acid sequence set forth in SEQ ID NO: 3.

8. The method of claim 1 , wherein the reacting step and the aminating step are performed in a single container.

9. The method of claim 8 , wherein all reagents are substantially added at the start of the reaction.

10. The method of claim 8 , wherein the reagents for the reacting step and the reagents for the aminating step are added to the single container at different times.

11. The method of claim 1 , wherein the reacting step and the aminating step are performed in separate containers.

12. A method for making L-glufosinate, comprising:

reacting D-glufosinate with a D-amino acid oxidase (DAAO) enzyme to form PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid) while aerating; and

aminating the PPO to L-glufosinate by a transaminase (TA) enzyme, using an amine group from one or more amine donors, wherein said DAAO enzyme is a mutant DAAO comprising one or more mutations at positions 54, 56, 58, 213, and 238, using SEQ ID NO: 2 as a reference sequence,

wherein the mutation at position 54 is selected from the group consisting of N54C, N54L, N54T, and N54V; the mutation at position 56 is T56M; and the mutation at position 58 is selected from the group consisting of F58A, F58G, F58H, F58N, F58Q, F58R, F58S,and F58T;

wherein at least 70% of the D-glufosinate is converted to L-glufosinate; and

wherein the method is performed ex vivo.

13. The method of claim 12 , wherein the TA enzyme is a GabT transaminase having the amino acid sequence set forth in SEQ ID NO: 3.

14. The method of claim 12 , wherein the amine donor is glutamate.

15. The method of claim 13 , wherein the one or more mutations comprise N54V, F58Q, and M213S.

16. The method of claim 12 , wherein the reacting step and the aminating step are performed in a single container.

17. The method of claim 16 , wherein all reagents are substantially added at the start of the reaction.

18. The method of claim 16 , wherein the reagents for the reacting step and the reagents for the aminating step are added to the single container at different times.

19. The method of claim 12 , wherein the reacting step and the aminating step are performed in separate containers.

20. The method of claim 12 , wherein the DAAO and TA enzymes are immobilized to a support.

21. The method of claim 1 , wherein the DAAO and TA enzymes are immobilized to a support.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2020
From: AGRIMETIS, LLC
To: BASF SE
Reel/Frame 054405/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2019
From: ALCASABAS, ANNETTE
To: ZUVASYNTHA LIMITED
Reel/Frame 047930/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: ACIDOPHIL, LLC
To: AGRIMETIS, LLC
Reel/Frame 042799/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: GRADLEY, MICHELLE LORRAINE
To: ZUVASYNTHA LIMITED
Reel/Frame 042799/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: GREEN, BRIAN MICHAEL
To: ACIDOPHIL, LLC
Reel/Frame 042981/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: ZUVASYNTHA LIMITED
To: AGRIMETIS, LLC
Reel/Frame 042981/0272 →
Continuity (4)
Provisional Application 62413240 · Oct 26, 2016
Provisional Application 62336989 · May 16, 2016
Provisional Application 62302421 · Mar 2, 2016
Related Publication 20170253897A1 · Sep 7, 2017